Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Luen SJ, Salgado R, Dieci MV, Vingiani A, Curigliano G, Gould RE, Castaneda C, D'Alfonso T, Sanchez J, Cheng E, Andreopoulou E, Castillo M, Adams S, Demaria S, Symmans WF, Michiels S, Loi S. Luen SJ, et al. Ann Oncol. 2019 Feb 1;30(2):236-242. doi: 10.1093/annonc/mdy547. Ann Oncol. 2019. PMID: 30590484 Free article.
Axl receptor tyrosine kinase expression in breast cancer.
D'Alfonso TM, Hannah J, Chen Z, Liu Y, Zhou P, Shin SJ. D'Alfonso TM, et al. J Clin Pathol. 2014 Aug;67(8):690-6. doi: 10.1136/jclinpath-2013-202161. Epub 2014 Jun 5. J Clin Pathol. 2014. PMID: 24904064 Free PMC article.
Subareolar Sclerosing Ductal Hyperplasia.
Cheng E, D'Alfonso TM, Arafah M, Marrero Rolon R, Ginter PS, Hoda SA. Cheng E, et al. Int J Surg Pathol. 2017 Feb;25(1):4-11. doi: 10.1177/1066896916677288. Epub 2016 Nov 10. Int J Surg Pathol. 2017. PMID: 27831531
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism.
Karagiannis GS, Pastoriza JM, Wang Y, Harney AS, Entenberg D, Pignatelli J, Sharma VP, Xue EA, Cheng E, D'Alfonso TM, Jones JG, Anampa J, Rohan TE, Sparano JA, Condeelis JS, Oktay MH. Karagiannis GS, et al. Sci Transl Med. 2017 Jul 5;9(397):eaan0026. doi: 10.1126/scitranslmed.aan0026. Sci Transl Med. 2017. PMID: 28679654 Free PMC article.
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Dieci MV, Radosevic-Robin N, Fineberg S, van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, D'Alfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, Adams S, Loi S, Salgado R; International Immuno-Oncology Biomarker Working Group on Breast Cancer. Dieci MV, et al. Semin Cancer Biol. 2018 Oct;52(Pt 2):16-25. doi: 10.1016/j.semcancer.2017.10.003. Epub 2017 Oct 9. Semin Cancer Biol. 2018. PMID: 29024776 Free article. Review.
77 results